TrialAmerican journal of physiology. Endocrinology and metabolism2026

Acute interleukin-1β antagonism decreases systemic inflammation, increases GLP-1 release, and modulates insulin secretion in individuals with prediabetes.

Justus S Fischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.